Skip to main content
Medical information Clinical review pending

Infection Testing

Metapneumonia Virus A RNA Detection Qualitative Test

Detects the presence of Metapneumonia Virus A RNA to diagnose respiratory infections. Uses Real Time PCR technology for accurate results.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, Lung tissues.
Results
Results are typically available within 4 working days. Communication via email within 48 hours or phone within 36 hours.
Preparation
No specific patient preparation is required. Please ensure you have signed the consent form and provide relevant clinical history.
Test priceKSh 14,450

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Metapneumonia Virus A RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms of respiratory illness (cough, wheezing, difficulty breathing)
  • ✓Diagnosis of viral respiratory infections
  • ✓Identifying the cause of pneumonia
  • ✓Monitoring outbreaks in healthcare settings
  • ✓Patients with risk factors for severe respiratory illness
02

In plain language

What this test helps you understand

This test helps identify the presence of Metapneumonia Virus A RNA, aiding in the diagnosis of respiratory infections caused by this specific virus. It assists healthcare providers in making informed decisions about patient management and treatment.
The Metapneumonia Virus A RNA Detection Qualitative Test is a diagnostic tool used to identify infections caused by the Metapneumonia virus. This virus commonly causes respiratory illnesses, especially in young children and individuals with compromised immune systems. Early diagnosis through this test is important for effective management and treatment.

This test specifically looks for the genetic material (RNA) of the Metapneumonia virus in samples collected from the respiratory tract. We use Real Time PCR technology, which is highly sensitive and specific, ensuring reliable results to guide clinical decisions.

Individuals experiencing symptoms like persistent cough, wheezing, shortness of breath, or fever, particularly during respiratory illness seasons, may benefit from this test. It is also recommended for those at higher risk of severe illness, such as infants, the elderly, and people with underlying health conditions.

Getting tested allows for confirmation of a Metapneumonia virus infection, helping healthcare providers determine the appropriate course of action. This can include supportive care, antiviral treatment if indicated, and measures to prevent the spread of the virus.

Consult your doctor to understand your results and discuss the next steps based on your specific situation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Please ensure you have signed the consent form and provide relevant clinical history.
SampleBronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, Lung tissues.
MethodologyReal Time PCR (Polymerase Chain Reaction).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of Metapneumonia Virus A RNA but does not quantify the viral load. A negative result does not completely rule out infection, especially if the sample was collected late in the illness or improperly. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Metapneumonia virus is a common respiratory virus that can cause symptoms similar to a cold or flu, but can also lead to more severe illness like pneumonia or bronchiolitis, especially in young children and older adults.
Testing is recommended for individuals with respiratory symptoms, especially if they are severe, persistent, or occur during known outbreaks. Those at high risk for complications should also consult their doctor.
Samples are typically collected from the respiratory tract using methods like nasal or throat swabs, sputum collection, or bronchial lavage, depending on the patient's condition and doctor's recommendation.
A positive result indicates that the Metapneumonia Virus A RNA was detected in your sample, suggesting an active infection. Your doctor will interpret this result in the context of your symptoms and medical history.
The turnaround time for results is typically within 4 working days. Results can be communicated via email within 48 hours or over the phone within 36 hours.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp